Volume 8, Issue 6, Pages (September 2014)

Slides:



Advertisements
Similar presentations
Thioredoxin and Its Reductase Are Present on Synaptic Vesicles, and Their Inhibition Prevents the Paralysis Induced by Botulinum Neurotoxins Marco Pirazzini,
Advertisements

The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells  Jungsook Cho, Donna L. Gruol  Journal of.
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
Nogo-p4 Suppresses TrkA Signaling Induced by Low Concentrations of Nerve Growth Factor Through NgR1 in Differentiated PC12 Cells Neurosignals 2016;24:25-39.
Okadaic-Acid-Induced Inhibition of Protein Phosphatase 2A Produces Activation of Mitogen-Activated Protein Kinases ERK1/2, MEK1/2, and p70 S6, Similar.
Volume 9, Issue 5, Pages (November 1998)
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
Volume 97, Issue 2, Pages (April 1999)
Haihong Ye, Rejji Kuruvilla, Larry S Zweifel, David D Ginty  Neuron 
Volume 123, Issue 1, Pages (July 2002)
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
Carlos Rio, Heather I Rieff, Peimin Qi, Gabriel Corfas  Neuron 
IGF-1 vs insulin: Respective roles in modulating sodium transport via the PI-3 kinase/Sgk1 pathway in a cortical collecting duct cell line  E. Gonzalez-Rodriguez,
Brent Berwin, Erik Floor, Thomas F.J Martin  Neuron 
Volume 46, Issue 4, Pages (May 2005)
PSA–NCAM Is Required for Activity-Induced Synaptic Plasticity
Volume 20, Issue 5, Pages (May 2004)
Volume 110, Issue 11, Pages (June 2016)
Calpain-Mediated mGluR1α Truncation: A Key Step in Excitotoxicity
Volume 13, Issue 2, Pages (January 2003)
Volume 15, Issue 4, Pages (August 2004)
Posttranslational Regulation of Ca2+-Activated K+ Currents by a Target-Derived Factor in Developing Parasympathetic Neurons  Priya Subramony, Sanja Raucher,
TRPV3 Channels Mediate Strontium-Induced Mouse-Egg Activation
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Graham R. Huesmann, David F. Clayton  Neuron 
A Tripartite Protein Complex with the Potential to Couple Synaptic Vesicle Exocytosis to Cell Adhesion in Brain  Stefan Butz, Masaya Okamoto, Thomas C.
Volume 25, Issue 1, Pages (January 2017)
Volume 15, Issue 4, Pages (August 2004)
Volume 50, Issue 2, Pages (April 2006)
Recombinant Scinderin Enhances Exocytosis, an Effect Blocked by Two Scinderin- Derived Actin-Binding Peptides and PIP2  L Zhang, M.G Marcu, K Nau-Staudt,
Volume 20, Issue 4, Pages (April 2004)
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 10, Issue 3, Pages (September 2011)
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Volume 50, Issue 2, Pages (April 2006)
Volume 12, Issue 8, Pages (August 2015)
Volume 25, Issue 5, Pages (November 2006)
Volume 19, Issue 6, Pages (May 2017)
Volume 6, Issue 1, Pages (January 1997)
Volume 18, Issue 4, Pages (April 1997)
Xin-hao Wang, Mu-ming Poo  Neuron 
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 30, Issue 1, Pages (January 2009)
Volume 19, Issue 1, Pages (April 2017)
Frida E. Kleiman, James L. Manley  Cell 
Self-Restrained B Cells Arise following Membrane IgE Expression
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance  Valeria R. Fantin, Julie St-Pierre,
Biochemical Characterization of S100A2 in Human Keratinocytes: Subcellular Localization, Dimerization, and Oxidative Cross-Linking1  Rohini Deshpande,
Nerve Growth Factor Receptor-Mediated Gene Transfer
Volume 18, Issue 5, Pages (May 1997)
Volume 88, Issue 5, Pages (May 2005)
Volume 16, Issue 7, Pages (August 2016)
Volume 60, Issue 3, Pages (September 2001)
Volume 56, Issue 5, Pages (November 1999)
Cultured Schwann Cells Constitutively Express the Myelin Protein P0
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 14, Issue 10, Pages (October 2007)
Volume 19, Issue 1, Pages (April 2017)
Growth Factor-Dependent Trafficking of Cerebellar NMDA Receptors via Protein Kinase B/Akt Phosphorylation of NR2C  Bo-Shiun Chen, Katherine W. Roche 
Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells
Volume 21, Issue 3, Pages (September 1998)
Volume 16, Issue 7, Pages (August 2016)
Yann Leverrier, Anne J. Ridley  Current Biology 
Volume 46, Issue 5, Pages (June 2012)
Volume 24, Issue 4, Pages (July 2018)
Venkatesh N Murthy, Thomas Schikorski, Charles F Stevens, Yongling Zhu 
Volume 19, Issue 6, Pages (May 2017)
Volume 25, Issue 11, Pages e4 (December 2018)
Presentation transcript:

Volume 8, Issue 6, Pages 1870-1878 (September 2014) Thioredoxin and Its Reductase Are Present on Synaptic Vesicles, and Their Inhibition Prevents the Paralysis Induced by Botulinum Neurotoxins  Marco Pirazzini, Domenico Azarnia Tehran, Giulia Zanetti, Aram Megighian, Michele Scorzeto, Silvia Fillo, Clifford C. Shone, Thomas Binz, Ornella Rossetto, Florigio Lista, Cesare Montecucco  Cell Reports  Volume 8, Issue 6, Pages 1870-1878 (September 2014) DOI: 10.1016/j.celrep.2014.08.017 Copyright © 2014 The Authors Terms and Conditions

Cell Reports 2014 8, 1870-1878DOI: (10.1016/j.celrep.2014.08.017) Copyright © 2014 The Authors Terms and Conditions

Figure 1 Thioredoxin Reductase and Thioredoxin Are Present in Nerve Terminals and Are Loosely Bound to the Surface of Synaptic Vesicles (A) The left panels show representative confocal images of the levator aureus longus mouse neuromuscular junction stained with primary antibodies specific for thioredoxin reductase (TrxR, green) and α-bungarotoxin (cyan); similarly, the right panels refer to thioredoxin (Trx, green) and α-bungarotoxin (cyan). As expected, both proteins appear to be present also in muscle fibers; scale bar, 10 μm. See also Figure S1A. (B) The immunoblot staining of different preparations from the rat brain (indicated on the top of the lanes; 10 μg of total lysate proteins per lane) after SDS-PAGE are shown. TrxR, anti-thioredoxin reductase; Trx, anti-thioredoxin; STX 1A, anti-syntaxin; SNAP25, anti-SNAP25; VAMP2, anti-VAMP2. The electrophoretic mobility corresponding to the different molecular weight markers is indicated. The asterisk indicates an immunoreactive band relative to an alternative splicing form of TrxR of 66 kDa (UniProt database). (C) This panel shows immunoblottings with different specific antibodies of free and active zone-docked synaptic vesicles immunoisolated with an antibody specific for synaptophysin and probed for TrxR presence. The four lanes on the right part of the panel show that TrxR is detached from SVs upon treatment with bicarbonate/carbonate pH 11 buffer (S, supernatant; P, pellet). In both panels, membranes were stripped and restained for SNARE proteins. Hashtags indicate antibody bands. Cell Reports 2014 8, 1870-1878DOI: (10.1016/j.celrep.2014.08.017) Copyright © 2014 The Authors Terms and Conditions

Figure 2 The BoNT/A-Induced Cleavage of SNAP25 Is Prevented in Cerebellar Granular Neurons by Thioredoxin Reductase Inhibitors (A) CGNs were treated with TrxR inhibitors (JUG, 20 μM; AUR, 1 μM; MYR, 75 μM; CUR, 100 μM) or vehicle (NC, no toxin; PC, toxin treated) at 37°C. After 30 min, BoNT/A 1 nM was added for an additional 30 min to all samples except NC, and then neurons were washed and incubated in the presence of the same concentration of inhibitors for an additional 2 hr. Samples were fixed and stained with an antibody specific for the C terminus of the BoNT/A-cleaved SNAP25 (SNAP251–197). Anti-BoNT/A-cleaved SNAP25 was detected with an Alexa Fluor 555-conjugated secondary antibody. Images shown are representative of three independent sets of experiments. Scale bar, 10 μm. See also Figure S2A. (B) Quantification of SNAP25 by immunoblotting. CGNs were preincubated for 30 min with the indicated concentration of inhibitor at 37°C, BoNT/A 1 nM was added for 15 min, cells were washed, and culture medium with the same concentration of inhibitor was restored and incubation prolonged for 12 hr at 37°C. Cells were lysed and the SNAP25 content was estimated with an antibody that recognizes both the cleaved and the intact form of SNAP25 and another one specific for VAMP2, as an internal control. The top left panel reports a typical immunoblot resulting from an experiment in which curcumin was present (NC, no toxin no inhibitor added; PC, no inhibitor plus BoNT/A 1 nM final concentration; the five right lanes refer to sample treated with the increasing curcumin concentrations indicated in the right panel). The other panels report the amount of SNAP25 determined as a ratio to VAMP2 staining, which serves as internal control, taking the value in nontreated cells (NC) as 100% in CGNs samples treated with the indicated amounts of the different inhibitors and with BoNT/A. SD values derive from three independent experiments performed in triplicate. See also Figures S2B and S2C. Similar results were obtained when 10 pM BoNT/A was left, together with inhibitors, for 12 hr at 37°C before cell lysis and evaluation of SNAP25 cleavage (not shown). Cell Reports 2014 8, 1870-1878DOI: (10.1016/j.celrep.2014.08.017) Copyright © 2014 The Authors Terms and Conditions

Figure 3 Inhibitors of Thioredoxin Prevent the SNAP25 Cleavage by BoNT/A in Cerebellar Granular Neurons (A) CGNs were treated with Trx inhibitors (PX-12 25 μM or EBS 30 μM) or vehicle (NC, no toxin; PC, toxin treated) at 37°C. After 30 min, BoNT/A 1 nM was added for an additional 30 min, neurons were washed, and the incubation with the same concentration of inhibitors was prolonged for 2 hr. Treated neurons were fixed and stained with an antibody specific for the BoNT/A-cleaved form of SNAP25 (SNAP251–197). BoNT/A-cleaved SNAP25 was detected with an Alexa Fluor 555-conjugated secondary antibody. These images are representative of three independent sets of experiments. Scale bar, 10 μm. See also Figure S3A. (B) Quantification of SNAP25 by immunoblotting. CGNs were preincubated for 30 min with the indicated concentration of inhibitor at 37°C, BoNT/A 1 nM (final concentration) was added for 15 min, cells were washed, and culture medium with the same concentration of inhibitor was restored and incubation prolonged for 12 hr at 37°C. Cells were lysed and the SNAP25 content was estimated with an antibody that recognizes both the cleaved and the intact form of SNAP25 and another one specific for VAMP2, as an internal control. The left panel reports the result of a typical experiment aimed at determining the effect of thioredoxin inhibitor PX-12. The right five lanes derive from samples exposed to increasing concentrations of PX-12 indicated in the middle panel. NC, no toxin added; PC, toxin added in absence of PX-12. The middle and right panels report the amount of SNAP25 determined as a ratio to VAMP2 staining, which serves as internal control in samples treated with the indicated amounts of the two inhibitors, taking the value of nontreated cells (NC) as 100%. SD values derive from three independent experiments performed in triplicates. See also Figures S3B and S3C. Similar results were obtained when 10 pM BoNT/A was left, together with inhibitors, for 12 hr at 37°C before cell lysis and evaluation of SNAP25 cleavage (not shown). Cell Reports 2014 8, 1870-1878DOI: (10.1016/j.celrep.2014.08.017) Copyright © 2014 The Authors Terms and Conditions

Figure 4 Thioredoxin and Thioredoxin Reductase Inhibitors Largely Prevent the Local Paralysis and Death Induced by BoNT/A (A and B) Digit abduction score (DAS) changes with time after injection of 15 pg of BoNT/A in the mouse hindlimb after a previous injection with the indicated TrxR (A) or Trx (B) inhibitors or vehicle only (PC); DAS scores for animals treated with inhibitors only are not shown for clarity. All values are means ± SEM from four individual experiments using at least three animals per condition. See also Figures S4A and S4B. (C) Representative traces of evoked postsynaptic potential by nerve stimulation in soleus muscles dissected at day 6 from mice treated as PC (left) or as in (A) (middle) or (B) (right). Traces represent intracellular recordings of evoked postsynaptic potentials following nerve stimulation (arrow), with resting membrane potential clamped at −70 mV. In BoNT/A-treated muscle fibers, no postsynaptic potentials could be evoked, indicating complete nerve block. Star indicates a spontaneous miniature end-plate potential. See also Figure S4C. (D) Ebselen reduces BoNT/A lethality. Adult male CD1 mice preconditioned with ebselen 7.5 mg/kg (n = 15) or vehicle (n = 15) (see Experimental Procedures) were i.p. injected with 2 × MLD50 of BoNT/A. The animals were monitored every 4 hr for 96 hr. The survival curves were compared and found to be significantly different (p < 0.0001). Cell Reports 2014 8, 1870-1878DOI: (10.1016/j.celrep.2014.08.017) Copyright © 2014 The Authors Terms and Conditions